low haptoglobin. His acrocyanosis had progressed to intense gangrene in "stock and glove" distribution. (Figures 1 & 2 ) Treatment was started with passive warming, resuscitation, antibiotics, and steroids. Treatment with intravenous steroids was ineffective and cytotoxic agents were not used due to sepsis and multi system organ failure. The patient's condition continued to deteriorate with the multiple system organ failure and eventually succumbed to death. 
Discussion:
Cold agglutinins hemolytic anemia is an autoimmune hemolytic anemia secondary to IgM antibodies that generally react with polysaccharide antigens on the RBC surface only at temperatures below that of the core temperature of the body. They are therefore called "cold agglutinins." Rarely, IgG antibodies have these reaction characteristics, occurring either alone or with IgM antibodies. 1 The antigens are the i antigen and the I antigen, coded by a gene on chromosome 14q. The haemolysis is due to complement fixation in the intravascular compartment, and the majority of the complement coated cells are destroyed extravascularly by the reticulo-endothelial system. 2 Cold agglutinin disease was first reported in animals in 1903 by Landsteiner, and first human case reported in 1918 by Clough. 3 It is a rare disease, most often affecting females in the seventh decade of life, with an incidence of one case per million people per year. 4 Cold agglutinins are produced either in response to infection 5 or by paraneoplastic or neoplastic growth. 6 The most common infectious agents are: Mycoplasma pneumoniae, and infectious mononucleosis. Less commonly, cold agglutinins are associated with other bacterial and viral diseases, such as Cytomegalovirus, Epstein-Barr virus, Legionella, Citrobacter, Influenza, Varicella and Listeria Monocytogenes. 4, 6 Most common symptoms include anemia -35 percent, acrocyanosis -24 percent, fatigue -21 percent, weakness or dyspnea on exertion -7 percent, hemoglobinuria -3 percent. 6 Diagnosis is made by presence of a high titer of cold agglutinins (excess of 1 in 10,000). Positive direct antiglobulin (Coombs) test for the presence of bound complement on red cells. The test is usually negative for bound IgG. The additional diagnosis of mycoplasma infection, infectious mononucleosis, or lymphoma should be made under appropriate clinical circumstances. 7 Avoidance of cold is the most beneficial therapy to prevent hemolysis. Over the years, treatment has been directed at suppressing the synthesis of the IgM monoclonal protein and has included corticosteroids, alkylating agents, azathioprine, interferon, and purine nucleoside analogues. 6, 7 Recently the monoclonal anti-CD20 antibody rituximab, alone or in combination with fludarabine has shown better results than corticosteroids and alkylating agents. 8 Plasmapheresis can be used as adjunctive treatment to physically remove the IgM antibody from the plasma, leading to a reduction in the rate of hemolysis. 9 9. Raynaud's phenomenon with necrosis of the extremities induced by Died cold agglutinin disease secondary to a T-cell lymphoma Talisman et al. 11 1998
Gangrene of the back, buttocks, fingers and toes caused by transient cold Amputation, agglutinemia induced by a cooling blanket in a patient with sepsis Survived Patel M, et al. 12 1993 Paroxysmal cold haemoglobinuria coexisting with cold agglutinins in Survived a patient with syphilis resulting in peripheral gangrene Freedman J, et al. 13 1985
Autoimmune hemolytic anemia with concurrence of warm and cold red Survived cell autoantibodies and a warm hemolysin.
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